The wanted company is active in the diagnostics and molecular medicine sector. It is interested in research and production of analysis kits for diabetes and central nervous system pathologies and others, or producers of oligonucleotides and/or enzymes. It can also evaluate Instrumentation, equipment, and software needed for analysis.

The company revenue is a maximum of €30M with a maximum EBITDA of €5M and is located in North America, Brazil, Europe (including the Nordics) but preferably in Germany, Spain, and/or France.

The buyer is a European pharmacogenetics company specialized in DNA analysis and molecular diagnostics kits for oncology, is looking for a company to create an international player. The buyer has an EBITDA of over €15M.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.